"Otamixaban 3D.png"@en . "S173RED00L"@en . "46618" . "Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial."@en . "4593439"^^ . . . . . . "193153-04-7" . . . . "Otamixaban \u00E9 um f\u00E1rmaco que age como inibidor direto do fator Xa."@pt . "1001368397"^^ . . "Methyl -2-{3-[aminomethyl]benzyl}-3-{[4-benzoyl]amino}butanoate"@en . "193153"^^ . . . "16350944"^^ . . . . "4"^^ . . . "Otamixaban"@it . "462266309"^^ . . . . . . . . "4"^^ . . "O=C[C@H][C@H]C"@en . . . "26"^^ . . "\u30AA\u30BF\u30DF\u30AD\u30B5\u30D0\u30F3"@ja . "25"^^ . "Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial."@en . . . "\u30AA\u30BF\u30DF\u30AD\u30B5\u30D0\u30F3\uFF08Otamixaban\uFF09\u306F\u3001\u30AD\u30B5\u30D0\u30F3\uFF08xaban\uFF09\u3068\u4ED8\u304F\u3053\u3068\u304B\u3089\u3082\u660E\u3089\u304B\u306A\u3088\u3046\u306B\u3001\u306E1\u7A2E\u3067\u3042\u308B\u3002CAS\u767B\u9332\u756A\u53F7\u306F193153-04-7\u3002"@ja . "S173RED00L" . . . . "Otamixaban"@pt . . "Otamixaban"@en . "\u30AA\u30BF\u30DF\u30AD\u30B5\u30D0\u30F3\uFF08Otamixaban\uFF09\u306F\u3001\u30AD\u30B5\u30D0\u30F3\uFF08xaban\uFF09\u3068\u4ED8\u304F\u3053\u3068\u304B\u3089\u3082\u660E\u3089\u304B\u306A\u3088\u3046\u306B\u3001\u306E1\u7A2E\u3067\u3042\u308B\u3002CAS\u767B\u9332\u756A\u53F7\u306F193153-04-7\u3002"@ja . . . . "Otamixaban \u00E9 um f\u00E1rmaco que age como inibidor direto do fator Xa."@pt . "changed"@en . . . . . "5496659"^^ . . . . . "L'Otamixaban (INN) \u00E8 un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunci\u00F2 che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III"@it . "46618"^^ . "PFGVNLZDWRZPJW-OPAMFIHVSA-N"@en . "none"@en . . "5496659" . . . . "L'Otamixaban (INN) \u00E8 un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunci\u00F2 che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III"@it . . "3363"^^ . "1"^^ . .